Analytical Data
-
基因名
Wnt3a
- Application
-
别名
Wnt-3a; Wnt 3a; WNT3A protein; Wnt3a
-
种属
Human
-
表达系统
E. coli
-
标签
N- His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P56704
-
表达区间
19-352aa
-
分子量
43.5 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Wnt3a is a pivotal member of the Wnt signaling pathway, which plays a crucial role in various biological processes including cell proliferation, differentiation, and tissue homeostasis. Dysregulation of Wnt3a has been implicated in several diseases, particularly in cancer and developmental disorders. Researchers have increasingly focused on recombinant Wnt3a protein for its potential therapeutic applications, specifically in regenerative medicine and cancer treatment. The production of recombinant Wnt3a allows for a more in-depth investigation into its mechanisms of action and interactions with other proteins within the signaling cascade. Moreover, understanding how Wnt3a influences stem cell behavior and tissue regeneration can lead to novel strategies for tissue engineering and repair. Recent advancements in recombinant protein technology have enhanced the yield and functionality of Wnt3a, facilitating in vitro and in vivo studies. Through these studies, scientists aim to elucidate the biological effects of Wnt3a, optimizing its use for targeted therapies and exploring its role in promoting regenerative processes. As research progresses, the therapeutic potential of recombinant Wnt3a continues to attract attention, with hopes of translating these findings into clinical applications for a variety of diseases.
